2nd Probiotics Congress: Europe

  • 999.00 Euro €
  • Published date: September 26, 2017
    • Rotterdam, South Holland, Netherlands

The 2nd Probiotics Congress: Europe is set to take place on 21 – 22 March in Rotterdam, The Netherlands. Designed with scientists, researchers and businesses in mind, this meeting focuses on identification, product development and regulation.

Leaders from academia and industry will present on topics across the vast field of dietary supplements, condensing it into two days of incisive presentations, roundtable debates and panel discussions.
Further opportunities to network and form partnerships can be found at the co-located 5th Microbiome R&D and Business Collaboration Forum: Europe.

Result 0 votes
Jane Williams
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-OVA T cell receptor (TCR) is constructed for the engineering of T cell to target OVA. The T cells are genetically modified through transduction with a retroviral vector expressing OVA-specific T cell receptor. And the vector produc...

  • Human anti-OVA (aa325-340) T cell receptor, pCDTCR1

    Human anti-OVA (aa325-340) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-OVA T cell receptor (TCR) is constructed for the engineering of T cell to target OVA. The T cells are genetically modified through transduction with a retroviral vector expressing OVA-specific T cell receptor. And the vector produc...

  • Human anti-NY-ESO-1 (aa117-139) T cell receptor, pCDTCR1

    Human anti-NY-ESO-1 (aa117-139) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-NY-ESO-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human NY-ESO-1. The T cells are genetically modified through transduction with a retroviral vector expressing NY-ESO-1-specific T cell receptor. ...